Similar results were obtained in a glioma patient study indicating its potential use as a predictive biomarker for RT, while another study determined MMP-13 as prognostic marker for tumor aggressiveness and recurrence in head and neck cancer patients (84, 85). Here, MMP13 is linked to neoplasm.